Preparation for Child Psych PRITE and Boards
| Line 5: | Line 5: | ||
* The incidence of MDD during pregnancy is 7.5%, while period prevalence is 12.7%. | * The incidence of MDD during pregnancy is 7.5%, while period prevalence is 12.7%. | ||
* Depression during pregnancy is associated with increased risk of pre-term birth and low birth-weight ([http://www.ncbi.nlm.nih.gov/pubmed/20921117 Meta-analysis], Grote 2010) | * Depression during pregnancy is associated with increased risk of pre-term birth and low birth-weight ([http://www.ncbi.nlm.nih.gov/pubmed/20921117 Meta-analysis], Grote 2010) | ||
| − | * Women treated with '''SSRI's''' have 2-3x greater risk for preterm birth and delivering low-birth-weight | + | * Women treated with '''SSRI's''' have 2-3x greater risk for preterm birth and delivering low-birth-weight infants, compared to women not treated with SSRIs. |
==Treatment== | ==Treatment== | ||
| Line 11: | Line 11: | ||
==References== | ==References== | ||
| − | [http://www.ncbi.nlm.nih.gov/pubmed/20921117 Groto NK. | + | [http://www.ncbi.nlm.nih.gov/pubmed/20921117] Groto NK. et.al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010 Oct;67(10):1012-24 |
Revision as of 04:04, 5 May 2013
Introduction
General overview of depression can be found in the main article.
Epidemiology
- The incidence of MDD during pregnancy is 7.5%, while period prevalence is 12.7%.
- Depression during pregnancy is associated with increased risk of pre-term birth and low birth-weight (Meta-analysis, Grote 2010)
- Women treated with SSRI's have 2-3x greater risk for preterm birth and delivering low-birth-weight infants, compared to women not treated with SSRIs.
Treatment
References
[1] Groto NK. et.al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010 Oct;67(10):1012-24